Belpointe Asset Management LLC Grows Stake in Axon Enterprise, Inc $AXON

Belpointe Asset Management LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 108.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,172 shares of the biotechnology company's stock after buying an additional 610 shares during the period. Belpointe Asset Management LLC's holdings in Axon Enterprise were worth $970,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of AXON. Jennison Associates LLC boosted its position in shares of Axon Enterprise by 23,203.7% during the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after buying an additional 611,418 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Axon Enterprise during the first quarter valued at $264,796,000. Westfield Capital Management Co. LP boosted its position in shares of Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock valued at $487,977,000 after buying an additional 212,931 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock valued at $4,540,005,000 after buying an additional 185,571 shares during the last quarter. Finally, Axiom Investors LLC DE purchased a new stake in shares of Axon Enterprise during the first quarter valued at $93,088,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have weighed in on AXON shares. Raymond James Financial reissued an "outperform" rating and issued a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Northland Securities set a $800.00 target price on Axon Enterprise in a report on Tuesday, August 5th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Bank of America increased their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $825.00 target price on shares of Axon Enterprise in a report on Monday, September 29th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $841.64.

Axon Enterprise Stock Down 1.0%

NASDAQ AXON opened at $714.60 on Wednesday. The stock's 50-day moving average price is $757.21 and its 200-day moving average price is $710.53. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52 week low of $420.49 and a 52 week high of $885.91. The company has a market capitalization of $56.10 billion, a P/E ratio of 176.44, a price-to-earnings-growth ratio of 28.02 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm's quarterly revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the company earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the transaction, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. This trade represents a 5.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total value of $5,919,039.10. Following the transaction, the insider owned 144,538 shares of the company's stock, valued at $108,417,953.80. This represents a 5.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 49,932 shares of company stock worth $37,978,216 over the last three months. 5.70% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.